Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Merit Cudkowicz

ALS · PHS

View

Dr. Jonathan Rosand

Neurocritical Care · Broad Institute

View

Dr. Maisha Robinson

Hospice & Palliative Care · Mayo Clinic Florida

View

Dr. Michael Kentris

Epilepsy · St. Elizabeth Medical Center

View

Dr. Daniel Correa

Epilepsy · AECOM

View

Dr. Aaron Berkowitz

General Neurology · UCSF

View

Dr. Jose Hernan Posas

Sports Neurology · UVA

View

Dr. Michael Okun

Movement Disorders · UF

View

Dr. Joseph Sirven

Epilepsy · Mayo Clinic College of Medicine

View

Dr. Rachel Marie Salas

Sleep Medicine · Johns Hopkins

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JADr. Jinsy Andrews
    Leading Voice

    Dr. Jinsy Andrews

    Neurology · Amyotrophic Lateral Sclerosis (ALS)
    NYU Langone Health
    jinsy

    Research

    DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial

    2026

    Via JAMA Network Open

    Research

    Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis

    2025

    Via JAMA Network Open

    Research

    Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series

    2025

    Via The Lancet

    Research

    Startle Reflex in Primary Lateral Sclerosis (PLS): A Comparison With Amyotrophic Lateral Sclerosis (ALS)

    2025

    Via Muscle & Nerve

    Research

    Current advances in 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee

    2024

    Via Transfusion

    Research

    The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials

    2024

    Via Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

    Research

    Access for ALL in ALS: A large‐scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis

    2024

    Via Muscle & Nerve

    Research

    Recent advances in the genetics of familial and sporadic ALS

    2024

    Via International review of neurobiology

    Research

    Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

    2022

    Via The New England Journal of Medicine

    Research

    Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review

    2022

    Via JAMA Neurology

    Research

    MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial

    2022

    Via Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

    Research

    Primary lateral sclerosis natural history study - planning, designing, and early enrollment

    2022

    Via Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

    Research

    Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development

    2022

    Via Annals of Neurology

    Research

    The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis

    2022

    Via Brain

    Research

    Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study

    2022

    Via Neurotherapeutics